Grant Pickering is the founder of SutroVax. Latest round: Series B. Backed by Frazier Healthcare Partners, Pivotal bioVenture Partners, Abingworth.
Grant Pickering is the CEO of SutroVax, a biopharmaceutical company focused on developing conjugate vaccines and complex antigen-based vaccines to prevent serious infectious diseases. The company announced the closing of a $60 million Series B financing in March 2017 and is advancing its lead pneumococcal conjugate vaccine (PCV) program.
Full founder directory · Investor directory · Company funding database · Fundraising library